share_log

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading 2.8% Higher

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML) Trading 2.8% Higher

ETRACS 槓桿式美國規模因子 TR ETN(NYSEARCA: IWML)交易價格上漲2.8%
Defense World ·  2023/03/28 02:34

ETRACS 2x Leveraged US Size Factor TR ETN (NYSEARCA:IWML – Get Rating)'s share price traded up 2.8% during mid-day trading on Monday . The company traded as high as $14.72 and last traded at $14.72. 183 shares were traded during trading, a decline of 81% from the average session volume of 939 shares. The stock had previously closed at $14.32.

在週一午盤交易中,ETRACS 2x槓桿美國規模因子TR ETN(NYSEARCA: IWML — 獲取評級)的股價上漲了2.8%。該公司的交易價格高達14.72美元,最後一次交易價格爲14.72美元。交易期間共交易183股,較939股的平均交易量下降了81%。該股此前收於14.32美元。

ETRACS 2x Leveraged US Size Factor TR ETN Stock Performance

ETRACS 2x 槓桿美國規模因子 TR ETN 股票表現

The stock's 50-day simple moving average is $16.89 and its two-hundred day simple moving average is $16.09.

該股的50天簡單移動平均線爲16.89美元,其200天簡單移動平均線爲16.09美元。

Featured Stories

精選故事

  • Get a free copy of the StockNews.com research report on ETRACS 2x Leveraged US Size Factor TR ETN (IWML)
  • 3 High Yields On Breakout Watch With Analyst Tailwinds
  • Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
  • 3 Financials The Insiders Are Buying
  • Can Carnival Cruise Lines Set Sail For New Highs?
  • If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
  • 免費獲取 StockNews.com 關於 ETRACS 2x 槓桿美國規模因子 TR ETN (IWML) 的研究報告的副本
  • 分析師利好在突破觀察中收穫3高收益率
  • 賽諾菲、Regeneron在有關慢性阻塞性肺病治療的重大新聞中股價大漲
  • 業內人士正在買入的 3 種金融產品
  • 嘉年華郵輪公司能否啓航創下新高?
  • 如果你關心安全,那就去桑迪斯普林銀行看看

Receive News & Ratings for ETRACS 2x Leveraged US Size Factor TR ETN Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ETRACS 2x Leveraged US Size Factor TR ETN and related companies with MarketBeat.com's FREE daily email newsletter.

每日接收 ETRACS 2x 槓桿美國規模因子 TR ETN 的新聞和評級 -在下面輸入您的電子郵件地址,通過Marketbeat.com的免費每日電子郵件時事通訊接收ETRACS 2x槓桿美國規模因子TRACS及相關公司的最新新聞摘要和分析師評級的簡明每日摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論